Empowered Funds LLC grew its holdings in shares of Concentrix Corporation (NASDAQ:CNXC - Free Report) by 21.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 306,784 shares of the company's stock after purchasing an additional 54,585 shares during the quarter. Empowered Funds LLC owned approximately 0.50% of Concentrix worth $8,394,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in CNXC. Larson Financial Group LLC increased its holdings in Concentrix by 224.9% during the third quarter. Larson Financial Group LLC now owns 692 shares of the company's stock worth $32,000 after buying an additional 479 shares during the last quarter. Geneos Wealth Management Inc. boosted its stake in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock valued at $34,000 after acquiring an additional 522 shares during the last quarter. Global Retirement Partners LLC boosted its stake in Concentrix by 1,032.5% in the fourth quarter. Global Retirement Partners LLC now owns 872 shares of the company's stock valued at $36,000 after acquiring an additional 795 shares during the last quarter. Webster Bank N. A. bought a new position in shares of Concentrix during the 1st quarter valued at approximately $41,000. Finally, Rothschild Investment LLC grew its position in shares of Concentrix by 52.0% during the 4th quarter. Rothschild Investment LLC now owns 1,146 shares of the company's stock valued at $48,000 after acquiring an additional 392 shares during the period. 90.34% of the stock is currently owned by institutional investors.
Concentrix Price Performance
Shares of NASDAQ CNXC opened at $24.49 on Friday. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18. Concentrix Corporation has a fifty-two week low of $19.12 and a fifty-two week high of $57.88. The stock has a market cap of $1.49 billion, a PE ratio of -1.15, a price-to-earnings-growth ratio of 0.45 and a beta of 0.45. The stock has a fifty day moving average of $24.61 and a 200-day moving average of $28.05.
Concentrix (NASDAQ:CNXC - Get Free Report) last issued its quarterly earnings data on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.64 by ($0.01). Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The company had revenue of $2.46 billion for the quarter, compared to analysts' expectations of $2.47 billion. During the same period last year, the company posted $2.70 EPS. The business's revenue for the quarter was up 1.9% on a year-over-year basis. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Equities research analysts anticipate that Concentrix Corporation will post 9.67 earnings per share for the current year.
Concentrix Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, August 4th. Stockholders of record on Friday, July 24th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date of this dividend was Friday, July 24th. Concentrix's dividend payout ratio is presently -6.75%.
Analyst Ratings Changes
Several research firms recently commented on CNXC. Weiss Ratings reiterated a "sell (d)" rating on shares of Concentrix in a research note on Friday, July 24th. Bank of America lowered their target price on Concentrix from $32.00 to $26.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 30th. Canaccord Genuity Group dropped their price target on Concentrix from $55.00 to $45.00 and set a "buy" rating on the stock in a research report on Tuesday, June 30th. Barrington Research cut their price target on Concentrix from $38.00 to $30.00 and set an "outperform" rating for the company in a research note on Tuesday, June 30th. Finally, Robert W. Baird lowered their price objective on Concentrix from $40.00 to $30.00 and set an "outperform" rating on the stock in a research note on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Concentrix presently has a consensus rating of "Hold" and an average price target of $32.75.
Check Out Our Latest Stock Analysis on CNXC
Concentrix Profile
(
Free Report)
Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Featured Articles
Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.